(Q44683757)

5 December 2017

title

Impact of infarct size on clinical and echocardiographic outcome in patients undergoing nonsurgical septal reduction therapy (English)

1 reference

5 December 2017

1 reference

Su min Chang

1

1 reference

5 December 2017

Mir Wais Sekandarzad

2

1 reference

5 December 2017

Sharon Jiang

3

1 reference

5 December 2017

Sherif Nagueh

4

1 reference

5 December 2017

William Spencer

5

1 reference

5 December 2017

Nasser Lakkis

6

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

5 December 2017

number of pages

3

1 reference

based on heuristic

inferred from page(s)

published in

American Heart Journal

1 reference

5 December 2017

volume

146

1 reference

5 December 2017

issue

6

1 reference

5 December 2017

page(s)

1112-1114

1 reference

The management of hypertrophic cardiomyopathy

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900504-0

Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900504-0

Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900504-0

Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900504-0

Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900504-0

Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900504-0

Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900504-0

Pressure-guided nonsurgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900504-0

Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900504-0

Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900504-0

Five years of percutaneous transluminal septal myocardial ablation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900504-0

10.1016/S0002-8703(03)00504-0

7 January 2021

Identifiers

DOI

1 reference

5 December 2017

1 reference